lobbying_activities: 2505581

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2505581	83fb25c1-b8de-46ff-baa3-1473e831658f	Q3	TAUZIN STRATEGIC NETWORKS	400786367	TAUZIN CONSULTANTS (ON BEHALF OF SORRENTO THERAPEUTICS, INC)	2020	third_quarter	MMM	Issues related to fair competition, the generic drug market, drug costs, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2020-10-09T12:13:11.977000-04:00